TY - JOUR T1 - Elevated levels of PM2.5 in crowded Subways of Cities with High COVID-19 related Mortality JF - medRxiv DO - 10.1101/2020.06.24.20138735 SP - 2020.06.24.20138735 AU - Yves Muscat Baron Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/26/2020.06.24.20138735.abstract N2 - BACKGROUND Recent literature indicates that the pollutant, particulate matter PM2.5, may have an impact on COVID-19 related mortality. COVID-19 has been found adherent to PM2.5 and may be involved in the transmission and the exacerbation of COVID-19 infection, possibly due to PM2.5’s adverse influence on respiratory immunity. The PM2.5 levels in underground subways have been found up to 90 times higher than the surface levels. Moreover, the commuter congestion in the presence of such high levels of PM2.5 further encouraged COVID-19 human to human transmission.METHOD The levels of PM2.5 were retrieved from literature assessing particulate matter PM2.5 measured on subway platforms in two groups of cities. These cities were differentiated by the COVID-19 population percentage mortality rate (0.007% vs 0.09% (p<0.0004) the city’s population, more than a 10-fold difference. Data regarding the number of stations, length of the networks (km) and the annual ridership were also obtained from literature related to underground commuting.RESULTS The population percentage mortality related to COVID-19 infection correlated significantly for both minimum (p<0.01) and maximum (p<0.00001) levels of PM2.5. The cities’ subways with low COVID-19 mortality had minimum platform PM2.5 levels of 27.4 (SD+/-17.2µg/m3) compared to 63.4µg/m3 (SD+/-10.8µg/m3) in cities with high COVID-19 associated mortality (p<0.01). Subway maximum levels of PM2.5 in cities with low COVID-19 mortality was 53.4µg/m3 (SD+/- 21.8µg/m3) while that of underground networks with high COVID-19 mortality had maximum platform PM2.5 levels of 172.1µg/m3 (SD+/-98µg/m3) (p<0.001). The cities with higher COVID-19 mortality had longer networks 230km (SD+/-111km) versus 119km (SD+/-99km) (p<0.03) and more stations 191 (SD+/-109) versus 102 (SD+/-94) (p<0.047). Although the annual ridership in the cities with the high COVID-19 mortality was higher (1034×106 vs 751×106) this did not achieve statistical significance. The maximum PM2.5 correlated with the number of stations (p<0.045) and the length of the networks (p< 0.044). The minimum PM2.5 did not achieve similar significant correlations to subway variables. Ridership significantly correlated with number of stations (p<0.01) and the length of the network (p<0.02).CONCLUSION Underground networks may have inherent characteristics accelerating spread of COVID-19 infection and consequent mortality. The highly elevated levels of PM2.5 in overcrowded subways with extensive reach may have acted as a co-factor to disseminate the pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNILAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available from literature quoted in the extensive Reference section. https://doi.org/10.1101/2020.04.05.20054502 https://doi10.3390/ijerph17082932 https://doi.org/10.1101/2020.05.03.20087056 https://doi10.21203/rs.3.rs-31884/v1 ER -